Skip to content
Topic

COVID-19

Papers (1132)

Perceived Risks and Ramifications of the COVID-19 Pandemic by Community and Healthcare Providers in Nepal

Nilam Bhandari, Dikshya Maharjan, Muna Silwal, Damaru Prasad Paneru & Anant Nepal · Journal of Advances in Medical and Pharmaceutical Sciences · 2021

Background: The COVID-19 pandemic has inflicted real suffering in many parts of the world and is expected to impact different sectors. Lockdown is considered to be an effective measure in slowing the spread of coronavirus. The study expects to understand community and healthcare...

Open access Research Article 10.9734/jamps/2021/v23i730246

Knowledge, Attitude, and Perception of COVID-19 Pandemic in Enugu, Southeast Nigeria- The Initial Experience

E. K. Mgbe, C. G. Mgbe, S. N. Ezeofor & J. F. Etiki · Journal of Advances in Medicine and Medical Research · 2021

Background: The world is experiencing a global corona virus (COVID-19) pandemic. As of 9th June 2020, over 7 million confirmed cases of coronavirus disease (COVID-19) and more than 400,000 deaths had been reported in more than 30 countries of the world according to World Health O...

Open access Research Article 10.9734/jammr/2021/v33i2031101

Assessment of Teachers and Students Experiences on Online Teaching during COVID-19 Pandemic: A Case-Study at a University Dental Teaching Hospital

Shilpa Bawane, Kalyani Bhate, Luke Kale, Lakshmi Shetty & Shreya Raut · Journal of Pharmaceutical Research International · 2021

Background: COVID-19 disease is a global phenomenon that is exerting its influence on a lot more than just health sector. Colleges, Institutes, and Schools were also part of the lockdown that followed the outbreak. Educational institutes have shifted from classroom teaching to on...

Open access Research Article 10.9734/jpri/2021/v33i45A32709

COVID-19 Pandemic: A Consequential Global Hazard to Public Mental Health

Pravina Mohan, M. Anusree & B. Nikitha · Journal of Pharmaceutical Research International · 2021

Background: The outbreak of COVID-19 infection in humans first reported in Wuhan (China) which has spread around the world and having a significant impact on global health and mental health. It has caused widespread psychosocial and behavioural changes as a result of mass hysteri...

Open access Research Article 10.9734/jpri/2021/v33i44B32693

Stigma Related to COVID-19 Positive Patients in Jeddah – Kingdom of Saudi Arabia during 2020 Pandemic

Ali Alawi Milibary & Najlaa Ahmed Mandoura · Journal of Pharmaceutical Research International · 2021

Background: COVID-19 has contributed to the development of stigma in the community of Jeddah, thus causing negative attitudes and beliefs toward individuals linked to the disease. Objective: To describe stigma related to COVID-19 positive patients and find out factors associated...

Open access Research Article 10.9734/jpri/2021/v33i44B32695

Myth and Truth about COVID-19 and Vaccination

Kunal Agrawal, Prakash Kute, Ashish Anjankar & Roshan Kumar Jha · Journal of Pharmaceutical Research International · 2021

SARS-CoV-2, also known as COVID-19, is a novel coronavirus that has spread from Wuhan, China to every continent except Antarctica. On March 11, 2020, the World Health Organization (WHO) changed the situation's classification from a public health emergency of international concern...

Open access Research Article 10.9734/jpri/2021/v33i44B32673

Hazardous Health Impact of Virtual Education during COVID-19

Abhisek Mishra, Byomakesh Debata, Pooja Patnaik, Bhawani Prasad Bag & Iswar Baitharu · Journal of Scientific Research and Reports · 2021

The rapid spread of COVID-19 compelled the infected nations to close down their educational institutions to check the rigor of spread. In such context, to provide uninterrupted education to the students, virtual education through internet was widely adopted. This paper throws a l...

Open access Research Article 10.9734/jsrr/2021/v27i830428

Assessing the Clinical Improvement in Patients with COVID-19 using Lopinavir-Ritonavir: A Systematic Review

Rania M. Magadmi · Journal of Pharmaceutical Research International · 2021

Aims: Globally the focus is towards finding an effective treatment for COVID-19 patients in order to suppress the spread of this pandemic disease. An antiviral combination of lopinavir-ritonavir is considered to be effective in treating COVID-19 patients. Therefore, the present s...

Open access Research Article 10.9734/jpri/2021/v33i44A32637

Chloroquine and Hydroxychloroquine in the Era of COVID-19: A Mini-Review

Sultan A. Alfawaz & Dalal Alfawaz · Journal of Pharmaceutical Research International · 2021

Coronavirus disease of 2019 (COVID-19) has severely affected global health, and caused a significant health burden worldwide in all, the patients, and healthy people. Globally, 17 August 2021, there have been 207,784,507 confirmed cases of COVID-19, including 4,370,424 deaths rep...

Open access Research Article 10.9734/jpri/2021/v33i44A32611

COVID-19 and Actor Well-being: A Serial Mediated Moderation of Mask Usage and Personal Health Engagement

Addo Prince Clement, Gumah Bernard, Ato Kwamena Sagoe, Ohemeng Asare Andy, Kulbo Nora Bakabbey, Takyi Nyankom Lydia & Kulbo Bassamar Dora · Asian Journal of Immunology · 2021

Wearing of face mask has become the new norm and a requirement for accessing public spaces. The current study explored the drives of self-regulation towards the purchase and use of face masks for actor wellbeing and public safety. The study adopted a cross-sectional survey approa...

Open access Research Article

Leptospirosis in COVID-19 Positive Pregnancy: A Rare Case Report Mimicking Hellp Syndrome

Aarshika Singh, Surekha Tayade, Ooha Thadiboina & Cherukuri Srinidhi · Journal of Pharmaceutical Research International · 2021

Leptospirosis in pregnancy is often underdiagnosed and not commonly reported due to its unusual appearance and rarity. It looks like HELLP syndrome, obstetric cholestasis, viral hepatitis & pregnancy-related acute fatty liver. Miscarriages in the first trimester, stillbirths,...

Open access Research Article 10.9734/jpri/2021/v33i43B32567

IgG Antibody Seroprevalence Post Covishield Vaccination in Western Uttar Pradesh: A Hospital Based Study

Sangeeta Kapoor, Sushil Yadav, V. K. Singh, Umme Afifa, Sudhir Kumar Gupta, Himani Muniyal & Anoop Kumar · Journal of Pharmaceutical Research International · 2021

Background: Covid-19, a zoonotic disease caused by Severe Acute Respiratory Syndrome Coronavirus - 2 (SARSCov-2) has emerged as a worldwide infection and has been declared pandemic since March, 2020, by WHO. This has brought about tremendous burden on the health care system of no...

Open access Research Article 10.9734/jpri/2021/v33i43B32549

Lung Delivery Systems to Optimize Pharmacotherapy of COVID-19: A Concise Review

Mohsen Geza. Alrashedi, Ahmed Geza. Alrashedi, Ahmed Shaker. Ali & Ibrahim M. Ibrahim · Journal of Pharmaceutical Research International · 2021

Background: COVID-19 is an ongoing viral pandemic caused by the SARS-COV-2 virus. Several drugs were repurposed for its management; however, most of these drugs were not ideal treatments by traditional methods of administration, whether given by injection or orally. This is due t...

Open access Research Article 10.9734/jpri/2021/v33i43B32552

The Impact of COVID-19 on Diabetes Mellitus and Hypertension: A Retrospective Study

S. Pavithra, S. Lavanya, P. Vaishnavi, A. Rakesh Rosario, Priyadharshini A & S. P. Ahalya · Journal of Pharmaceutical Research International · 2021

COVID-19 is a pathogenic virus that caused a pandemic outbreak in December 2019. The impact of this virus may be severe in the patients having co-morbidities like diabetes, hypertension, Chronic Kidney Disease, cardiovascular disease, etc. Aim and Objectives: This study Aims in A...

Open access Research Article 10.9734/jpri/2021/v33i43B32526